Gordon Campbell | Parliament TV | Parliament Today | News Video | Crime | Employers | Housing | Immigration | Legal | Local Govt. | Maori | Welfare | Unions | Youth | Search

 

Cannabis scheme heading in the right direction

Cannabis scheme heading in the right direction

“New Zealanders fought hard to achieve strong parliamentary support for medicinal cannabis last year. It’s now really important people have their say on the design of the regulations to ensure sound and sensible patient access,” says Paul Manning, Executive Director of Helius Therapeutics, the country’s largest medicinal cannabis firm.

Mr Manning was responding to the Ministry of Health’s release of its discussion document today on proposed regulations for New Zealand’s Medicinal Cannabis Scheme. The industry and public have until 5.00pm on 7 August to have their say.

“Helius strongly believes every New Zealander has a natural right to a pain-free existence and to improve their quality of life with medicinal cannabis. Primarily, the regulations need to ensure patient safety, access, and affordability. I’m pleased to see these key outcomes are broadly guiding the discussion document. The Ministry has done an excellent job on the fundamentals required to establish widespread social and economic benefits,” he says.

Since the Misuse of Drugs (Medicinal Cannabis) Amendment Act was passed in December last year, Helius Therapeutics has been working closely with Ministry of Health officials who Mr Manning says are fully engaged and committed to getting it right.

“We applaud the Ministry of Health’s pragmatic and workable approach to the proposed regulations, and the statements made today by Minister David Clark. However, patients will continue to face substantial barriers to access if a specialist recommendation is required before a GP can prescribe. This extra step could significantly impede patient access to medicinal cannabis.

“Helius has strongly advocated for general practitioners to be given professional discretion to prescribe medicinal cannabis for any condition – discretion like they have with other prescription medicines. If people agree that a specialist recommendation should not be required, they now need to have their say in the consultation,” he says.

In the areas of cultivation, manufacturing, and testing, Mr Manning says Helius is well positioned to deliver medicinal cannabis products that meet the proposed quality standards.

“This discussion document sets high yet workable cultivation and manufacturing standards. Regulators have made sure all the right components are in place to create a globally-competitive export industry.”

He says Helius Therapeutics will now consider its formal position on all the many options and proposals in the discussion document. However, he says on initial assessment the Ministry of Health is heading in the right direction.

“The challenge now, for both the industry and the public, is to provide considered responses within the consultation timeframe. A regulatory regime needs to be in place by the end of this year, with products more widely available to patients from the first quarter of 2020. Time is of the essence.

Parliament may have passed the medicinal cannabis bill last year, but this is now about writing the manual. It’s critical the Medicinal Cannabis Scheme firstly ensures patients can readily access high quality products. The New Zealand public has demanded nothing less,” says Mr Manning.

www.helius.co.nz

-- ENDS --


© Scoop Media

 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

Gordon Campbell: On Chilling The Warm Fuzzies About The US/China Trade Deal

Hold the champagne, folks. This week’s China/US deal is more about a change in tone between the world’s two biggest economies – thank goodness they’re not slapping more tariffs on each other! - than a landmark change in substance. The high walls of US and Chinese tariffs built in recent years will largely remain intact, and few economists are predicting the deal will significantly boost the growth prospects for a slowing US economy. As the New York Times noted this morning, the likes of New Zealand will still face the trade barriers imposed by the Trump administration during the recent rounds of fighting. More>>

 

PGF Kaikōura $10.88M: Boost In Tourism & Business

The Provincial Growth Fund (PGF) is investing $10.88 million to boost business and tourism opportunities in Kaikōura, Parliamentary Undersecretary for Regional Economic Development, Fletcher Tabuteau announced today. More>>

ALSO:

Whitebaiting: Govt Plans To Protect Announced

With several native whitebait species in decline the Minister of Conservation Eugenie Sage has today released proposals to standardise and improve management of whitebait across New Zealand. More>>

ALSO:

Education: Resource For Schools On Climate Change

New resource for schools to increase awareness and understanding of climate change... More>>

ALSO:

In Effect April: New Regulations For Local Medicinal Cannabis

Minister of Health Dr David Clark says new regulations will allow local cultivation and manufacture of medicinal cannabis products that will potentially help ease the pain of thousands of people. More>>

ALSO:


RNZ: New Year Honours: Sporting Greats Among Knights And Dames

Six new knights and dames, including Silver Ferns coach Dame Noeline Taurua and economist Professor Dame Marilyn Waring, have been created in today's New Year's Honours List. The list of 180 recipients - 91 women and 89 men - leans heavily on awards for community service, arts and the media, health and sport.
More>>

ALSO:

Gordon Campbell: On What An Inquiry Might Look Like

Presumably, if there is to be a ministerial inquiry (at the very least) into the Whakaari/White Island disaster, it will need to be a joint ministerial inquiry. That’s because the relevant areas of responsibility seem to be so deeply interwoven... More>>

ALSO:


 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 


 

InfoPages News Channels